US 6121266
Pyridazines as interleukin-1.beta. converting enzyme inhibitors
expired A61PA61P19/02A61P29/00
Quick answer
US patent 6121266 (Pyridazines as interleukin-1.beta. converting enzyme inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P19/02, A61P29/00, A61P35/00, A61P43/00